SG10201705118RA - Dna element having the activity of enhancing foreign gene expression - Google Patents
Dna element having the activity of enhancing foreign gene expressionInfo
- Publication number
- SG10201705118RA SG10201705118RA SG10201705118RA SG10201705118RA SG10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA SG 10201705118R A SG10201705118R A SG 10201705118RA
- Authority
- SG
- Singapore
- Prior art keywords
- activity
- gene expression
- foreign gene
- dna element
- enhancing foreign
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010154782 | 2010-07-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201705118RA true SG10201705118RA (en) | 2017-07-28 |
Family
ID=44630215
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2014009187A SG2014009187A (en) | 2010-07-07 | 2011-07-06 | Dna element having the activity of enhancing foreign gene expression |
SG10201705118RA SG10201705118RA (en) | 2010-07-07 | 2011-07-06 | Dna element having the activity of enhancing foreign gene expression |
SG10201505354PA SG10201505354PA (en) | 2010-07-07 | 2011-07-06 | Dna element having the activity of enhancing foreign gene expression |
SG2012094330A SG186788A1 (en) | 2010-07-07 | 2011-07-06 | Dna element having the activity of enhancing foreign gene expression |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2014009187A SG2014009187A (en) | 2010-07-07 | 2011-07-06 | Dna element having the activity of enhancing foreign gene expression |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201505354PA SG10201505354PA (en) | 2010-07-07 | 2011-07-06 | Dna element having the activity of enhancing foreign gene expression |
SG2012094330A SG186788A1 (en) | 2010-07-07 | 2011-07-06 | Dna element having the activity of enhancing foreign gene expression |
Country Status (14)
Country | Link |
---|---|
US (3) | US9371543B2 (en) |
EP (3) | EP2684961B1 (en) |
JP (2) | JP5859988B2 (en) |
KR (3) | KR101856927B1 (en) |
CN (3) | CN103080321A (en) |
AU (3) | AU2011274864B2 (en) |
BR (1) | BR112012033780A2 (en) |
CA (2) | CA2916937A1 (en) |
ES (3) | ES2701091T3 (en) |
IL (1) | IL243763A0 (en) |
RU (1) | RU2013104989A (en) |
SG (4) | SG2014009187A (en) |
TW (2) | TW201604280A (en) |
WO (1) | WO2012005378A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101856927B1 (en) * | 2010-07-07 | 2018-05-10 | 다이이찌 산쿄 가부시키가이샤 | Dna element having the activity of enhancing foreign gene expression |
SG11201402476XA (en) * | 2011-11-28 | 2015-02-27 | Daiichi Sankyo Co Ltd | Promoter derived from human gene |
EP3521428A4 (en) * | 2016-10-03 | 2020-06-24 | Daiichi Sankyo Company, Limited | PROMOTER OF Hspa5 GENE |
CN107881174B (en) * | 2017-11-22 | 2022-06-03 | 张宝会 | Method for regulating and controlling translation level gene expression and application |
AU2020447192A1 (en) * | 2020-05-11 | 2023-01-19 | Samsung Bioepis Co., Ltd. | Human genome-derived polynucleotide and method for producing polypeptide of interest using same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA891067B (en) * | 1988-02-12 | 1990-04-25 | Commw Scient Ind Res Org | Pox virus vectors |
US20070161003A1 (en) * | 2003-09-29 | 2007-07-12 | Morris David W | Novel therapeutic targets in cancer |
EP2105742A1 (en) * | 2008-03-26 | 2009-09-30 | Sanofi-Aventis | Use of cathepsin C |
JP5344682B2 (en) * | 2008-12-26 | 2013-11-20 | グローブライド株式会社 | Fishing line guide and manufacturing method of fishing line guide |
KR101856927B1 (en) * | 2010-07-07 | 2018-05-10 | 다이이찌 산쿄 가부시키가이샤 | Dna element having the activity of enhancing foreign gene expression |
SG11201402476XA (en) * | 2011-11-28 | 2015-02-27 | Daiichi Sankyo Co Ltd | Promoter derived from human gene |
-
2011
- 2011-07-06 KR KR1020187005003A patent/KR101856927B1/en active IP Right Grant
- 2011-07-06 EP EP13186031.4A patent/EP2684961B1/en active Active
- 2011-07-06 ES ES15188915T patent/ES2701091T3/en active Active
- 2011-07-06 CN CN2011800430998A patent/CN103080321A/en active Pending
- 2011-07-06 EP EP15188915.1A patent/EP3026117B1/en active Active
- 2011-07-06 JP JP2012555988A patent/JP5859988B2/en active Active
- 2011-07-06 SG SG2014009187A patent/SG2014009187A/en unknown
- 2011-07-06 KR KR1020137000305A patent/KR101833570B1/en active IP Right Grant
- 2011-07-06 CN CN201410141682.8A patent/CN103865931B/en active Active
- 2011-07-06 CA CA2916937A patent/CA2916937A1/en not_active Abandoned
- 2011-07-06 CA CA2804381A patent/CA2804381C/en not_active Expired - Fee Related
- 2011-07-06 ES ES11743651.9T patent/ES2564227T3/en active Active
- 2011-07-06 SG SG10201705118RA patent/SG10201705118RA/en unknown
- 2011-07-06 CN CN201610282337.5A patent/CN105950621B/en active Active
- 2011-07-06 SG SG10201505354PA patent/SG10201505354PA/en unknown
- 2011-07-06 AU AU2011274864A patent/AU2011274864B2/en active Active
- 2011-07-06 KR KR1020187005004A patent/KR101920187B1/en active IP Right Grant
- 2011-07-06 ES ES13186031.4T patent/ES2565428T3/en active Active
- 2011-07-06 BR BR112012033780A patent/BR112012033780A2/en not_active IP Right Cessation
- 2011-07-06 SG SG2012094330A patent/SG186788A1/en unknown
- 2011-07-06 WO PCT/JP2011/065916 patent/WO2012005378A2/en active Application Filing
- 2011-07-06 RU RU2013104989/10A patent/RU2013104989A/en not_active Application Discontinuation
- 2011-07-06 EP EP11743651.9A patent/EP2591113B1/en active Active
- 2011-07-06 TW TW104134850A patent/TW201604280A/en unknown
- 2011-07-06 TW TW100123779A patent/TWI507523B/en not_active IP Right Cessation
-
2012
- 2012-12-27 US US13/728,809 patent/US9371543B2/en active Active
-
2015
- 2015-12-17 JP JP2015245827A patent/JP6039048B2/en active Active
-
2016
- 2016-01-25 IL IL243763A patent/IL243763A0/en unknown
- 2016-05-23 US US15/162,294 patent/US10407694B2/en active Active
- 2016-06-02 AU AU2016203681A patent/AU2016203681B2/en active Active
-
2018
- 2018-01-30 AU AU2018200686A patent/AU2018200686B2/en active Active
-
2019
- 2019-07-26 US US16/523,547 patent/US11060108B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2612917T1 (en) | Antisense nucleic acid | |
HK1198704A1 (en) | Dna polymerases with improved activity dna | |
EP2791159A4 (en) | Modified nucleic acids, and acute care uses thereof | |
EP2632260A4 (en) | Leucine-rich repeat kinase enzyme activity | |
HK1207880A1 (en) | Improved enzyme variants | |
EP2599866A4 (en) | Novel nucleic acid having adjuvant activity and use thereof | |
EP2487238A4 (en) | Hair shape susceptibility gene | |
GB201004475D0 (en) | Gene silencing | |
EP2554667A4 (en) | Novel cellulase gene | |
HK1188608A1 (en) | Dna expression construct dna | |
EP2649993A4 (en) | Stabilizer of acetaminophen | |
IL226536A (en) | Targeted alteration of dna | |
IL243763A0 (en) | Dna element with foreign gene expression enhancement activity and uses thereof | |
GB2502195B (en) | Purification of nucleic acids | |
EP2451976A4 (en) | Nucleic acid nano-biosensors | |
IL226537A (en) | Targeted alteration of dna with oligonucleotides | |
HK1199064A1 (en) | Promoter derived from human gene | |
EP2702999A4 (en) | Brain-targeting functional nucleic acid and use thereof | |
EP2536741A4 (en) | Gene fusion targeted therapy | |
EP2616813A4 (en) | Host supported genetic biosensors | |
EP2535415A4 (en) | Modified nucleotide molecules of xylanase and application thereof | |
GB201021720D0 (en) | Gene variant | |
GB201010471D0 (en) | Gene variant | |
GB201215484D0 (en) | Optical characterisation of DNA and/or RNA | |
HK1201420A1 (en) | Use of amylase enzyme |